BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19766964)

  • 1. Iron sufficient to cause hepatic fibrosis and ascites does not cause cardiac arrhythmias in the gerbil.
    Kaiser L; Davis JM; Patterson J; Johnson AL; Bohart G; Olivier NB; Schwartz KA
    Transl Res; 2009 Oct; 154(4):202-13. PubMed ID: 19766964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron does not cause arrhythmias in the guinea pig model of transfusional iron overload.
    Kaiser L; Davis J; Patterson J; Boyd RF; Olivier NB; Bohart G; Schwartz KA
    Comp Med; 2007 Aug; 57(4):383-9. PubMed ID: 17803053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetaminophen combinations protect against iron-induced cardiac damage in gerbils.
    Walker EM; Morrison RG; Dornon L; Laurino JP; Walker SM; Studeny M; Wehner PS; Rice KM; Wu M; Blough ER
    Ann Clin Lab Sci; 2009; 39(4):378-85. PubMed ID: 19880766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy.
    Laurita KR; Chuck ET; Yang T; Dong WQ; Kuryshev YA; Brittenham GM; Rosenbaum DS; Brown AM
    J Lab Clin Med; 2003 Aug; 142(2):83-9. PubMed ID: 12960954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetaminophen protects against iron-induced cardiac damage in gerbils.
    Walker EM; Epling CP; Parris C; Cansino S; Ghosh P; Desai DH; Morrison RG; Wright GL; Wehner P; Mangiarua EI; Walker SM; Blough ER
    Ann Clin Lab Sci; 2007; 37(1):22-33. PubMed ID: 17311866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy.
    Yang T; Brittenham GM; Dong WQ; Levy MN; Obejero-Paz CA; Kuryshev YA; Brown AM
    J Lab Clin Med; 2003 Nov; 142(5):332-40. PubMed ID: 14647037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy.
    Obejero-Paz CA; Yang T; Dong WQ; Levy MN; Brittenham GM; Kuryshev YA; Brown AM
    J Lab Clin Med; 2003 Feb; 141(2):121-30. PubMed ID: 12577048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adiastole caused by a secondary cardiac hemochromatosis. Successful treatment with an iron chelating agent].
    Baudouy P; Lombrail P; Azancot I; Piekarski A; Martin E; Slama R
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1240-6. PubMed ID: 6418103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of colloidal iron overload on renal and hepatic siderosis and the femur in male rats.
    Kudo H; Suzuki S; Watanabe A; Kikuchi H; Sassa S; Sakamoto S
    Toxicology; 2008 Apr; 246(2-3):143-7. PubMed ID: 18289763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction.
    Schwartz KA; Li Z; Schwartz DE; Cooper TG; Braselton WE
    J Appl Physiol (1985); 2002 Aug; 93(2):746-51. PubMed ID: 12133887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload.
    Carthew P; Dorman BM; Edwards RE; Francis JE; Smith AG
    Lab Invest; 1993 Aug; 69(2):217-22. PubMed ID: 7688836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cardiac and hepatic iron overload in thalassaemic patients by magnetic resonance: a four year observational study.
    Candini G; Lappi S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():204-7. PubMed ID: 19337179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron.
    Asare GA; Paterson AC; Kew MC; Khan S; Mossanda KS
    J Pathol; 2006 Jan; 208(1):82-90. PubMed ID: 16278820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic iron overload and hepatocellular carcinoma.
    Kew MC
    Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of ECG voltage in cirrhotic patients.
    Madias JE
    Europace; 2007 Mar; 9(3):175-81. PubMed ID: 17344308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Holter electrocardiogram in iron-overloaded hemoglobinopathies.
    Qureshi N; Avasarala K; Foote D; Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():476-80. PubMed ID: 16339701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model.
    Wang ZJ; Lian L; Chen Q; Zhao H; Asakura T; Cohen AR
    Radiology; 2005 Mar; 234(3):749-55. PubMed ID: 15734931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of hepatic iron overload.
    Brunt EM
    Semin Liver Dis; 2005 Nov; 25(4):392-401. PubMed ID: 16315133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dose-dependent effects of chronic iron overload on the production of oxygen free radicals and vitamin E concentrations in the liver of a murine model.
    McCullough KD; Bartfay WJ
    Biol Res Nurs; 2007 Apr; 8(4):300-4. PubMed ID: 17456591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron metabolism and toxicity.
    Papanikolaou G; Pantopoulos K
    Toxicol Appl Pharmacol; 2005 Jan; 202(2):199-211. PubMed ID: 15629195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.